Association of Women Authors With Women Enrollment in Clinical Trials of Atrial Fibrillation

Safi U. Khan; Charumathi Raghu Subramanian; Muhammad Zia Khan; Ahmad N. Lone; Swapna Talluri; Janet K. Han; Nino Isakadze; Annabelle Santos Volgman; Erin D. Michos

doi:10.1161/JAHA.121.024233

Association of Women Authors With Women Enrollment in Clinical Trials of Atrial Fibrillation

Safi U. Khan, Charumathi Raghu Subramanian, Muhammad Zia Khan, Ahmad N. Lone, Swapna Talluri, Janet K. Han, Nino Isakadze, Annabelle Santos Volgman, Erin D. Michos

School of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	e024233
Journal	Journal of the American Heart Association
Volume	11
Issue number	5
DOIs	https://doi.org/10.1161/JAHA.121.024233
State	Published - Mar 1 2022

Keywords

atrial fibrillation
clinical trials
diversity
gender equity
leadership
women

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1161/JAHA.121.024233

Cite this

@article{a112ad576adc40d1b3f5952d4ebb6f75,

title = "Association of Women Authors With Women Enrollment in Clinical Trials of Atrial Fibrillation",

keywords = "atrial fibrillation, clinical trials, diversity, gender equity, leadership, women",

author = "Khan, {Safi U.} and Subramanian, {Charumathi Raghu} and Khan, {Muhammad Zia} and Lone, {Ahmad N.} and Swapna Talluri and Han, {Janet K.} and Nino Isakadze and Volgman, {Annabelle Santos} and Michos, {Erin D.}",

note = "Funding Information: Dr Michos is supported by the Amato Fund in Women{\textquoteright}s Cardiovascular Health at Johns Hopkins University. Drs. Michos and Isakadze are both supported by an American Heart Association grant 20SFRN35380046. Funding Information: Dr Michos reports advisory boards relationships with AstraZeneca, Amarin, Bayer, Boehringer Ingelheim, Esperion, Novartis, Novo Nordisk, and Pfizer. Dr Volgman is supported by the McMullan-Eybel Endowment Chair Fund at Rush University; has served as MSD/Bayer Virtual Global Advisory Board Member; has received support from the Bristol Myers Squibb Foundation Diverse Clinical Investigator Career Development Program (DCICDP); has served on the Novo Nordisk Virtual Advisory Board on Healthcare Disparities, Novartis Clinical Trial, and National Institutes of Health Clinical Trials; and has stock in Apple Inc. Dr Han received speaking honoraria from Abbott, Boston Scientific, and Medtronic. The other authors do not report disclosures. Funding Information: Dr Michos is supported by the Amato Fund in Women?s Cardiovascular Health at Johns Hopkins University. Drs. Michos and Isakadze are both supported by an American Heart Association grant 20SFRN35380046.",

year = "2022",

month = mar,

day = "1",

doi = "10.1161/JAHA.121.024233",

language = "English (US)",

volume = "11",

journal = "Journal of the American Heart Association",

issn = "2047-9980",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Association of Women Authors With Women Enrollment in Clinical Trials of Atrial Fibrillation

AU - Khan, Safi U.

AU - Subramanian, Charumathi Raghu

AU - Khan, Muhammad Zia

AU - Lone, Ahmad N.

AU - Talluri, Swapna

AU - Han, Janet K.

AU - Isakadze, Nino

AU - Volgman, Annabelle Santos

AU - Michos, Erin D.

N1 - Funding Information: Dr Michos is supported by the Amato Fund in Women’s Cardiovascular Health at Johns Hopkins University. Drs. Michos and Isakadze are both supported by an American Heart Association grant 20SFRN35380046. Funding Information: Dr Michos reports advisory boards relationships with AstraZeneca, Amarin, Bayer, Boehringer Ingelheim, Esperion, Novartis, Novo Nordisk, and Pfizer. Dr Volgman is supported by the McMullan-Eybel Endowment Chair Fund at Rush University; has served as MSD/Bayer Virtual Global Advisory Board Member; has received support from the Bristol Myers Squibb Foundation Diverse Clinical Investigator Career Development Program (DCICDP); has served on the Novo Nordisk Virtual Advisory Board on Healthcare Disparities, Novartis Clinical Trial, and National Institutes of Health Clinical Trials; and has stock in Apple Inc. Dr Han received speaking honoraria from Abbott, Boston Scientific, and Medtronic. The other authors do not report disclosures. Funding Information: Dr Michos is supported by the Amato Fund in Women?s Cardiovascular Health at Johns Hopkins University. Drs. Michos and Isakadze are both supported by an American Heart Association grant 20SFRN35380046.

PY - 2022/3/1

Y1 - 2022/3/1

KW - atrial fibrillation

KW - clinical trials

KW - diversity

KW - gender equity

KW - leadership

KW - women

UR - http://www.scopus.com/inward/record.url?scp=85125554641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85125554641&partnerID=8YFLogxK

U2 - 10.1161/JAHA.121.024233

DO - 10.1161/JAHA.121.024233

M3 - Letter

C2 - 35191324

AN - SCOPUS:85125554641

SN - 2047-9980

VL - 11

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

IS - 5

M1 - e024233

ER -

Association of Women Authors With Women Enrollment in Clinical Trials of Atrial Fibrillation

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this